Nufoɔ kokoran

From Wikipedia
Jump to navigation Jump to search

Enema etumi de nufo kokoram ba no bi ye nna, kese,obi a o.[1]

The balance of benefits versus harms of breast cancer screening is controversial. A 2013 Cochrane review stated that it is unclear if mammographic screening does more good or harm.[2] A 2009 review for the US Preventive Services Task Force found evidence of benefit in those 40 to 70 years of age,[3] and the organization recommends screening every two years in women 50 to 74 years old.[4] The medications tamoxifen or raloxifene may be used in an effort to prevent breast cancer in those who are at high risk of developing it.[5] Surgical removal of both breasts is another preventative measure in some high risk women.[5] In those who have been diagnosed with cancer, a number of treatments may be used, including surgery, radiation therapy, chemotherapy, hormonal therapy and targeted therapy.[1] Types of surgery vary from breast-conserving surgery to mastectomy.[6][7] Breast reconstruction may take place at the time of surgery or at a later date. In those in whom the cancer has spread to other parts of the body, treatments are mostly aimed at improving quality of life and comfort.[7]

  1. 1.0 1.1 "Breast Cancer Treatment (PDQ®)". NCI. 23 May 2014. Retrieved 29 June 2014. 
  2. Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
  3. Nelson, HD; Tyne, K; Naik, A; Bougatsos, C; Chan, B; Nygren, P; Humphrey, L (November 2009). Screening for Breast Cancer: Systematic Evidence Review Update for the US Preventive Services Task Force [Internet]. PMID 20722173. 
  4. Siu, Albert L. (12 January 2016). "Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement". Annals of Internal Medicine. doi:10.7326/M15-2886. 
  5. 5.0 5.1 World Cancer Report 2014. World Health Organization. 2014. pp. Chapter 5.2. ISBN 92-832-0429-8. 
  6. Nhwɛsode:Citation
  7. 7.0 7.1 "Breast Cancer Treatment (PDQ®)". NCI. 26 June 2014. Retrieved 29 June 2014.